Single High-Dose Buprenorphine for Opioid Craving During Withdrawal

Trials - United Kingdom
doi 10.1186/s13063-018-3055-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC